Uremic pateints with itching
Dietary SupplementActivated charcoal
NCT Number: NCT05634083
Itching is a widespread and disturbing complain from patients with chronic kidney disease (CKD); epidemiologic data have suggested that approximately 40% of patients with end-stage renal disease experience moderate to severe itching. The pathogenesis of renal pruritus is multifactorial. Triggering factors may include uremia-related abnormalities, accumulation of uremic toxins, systemic inflammation and cutaneous xerosis. Indoxyl sulfate (IS) is a protein-bound uremic toxin resulting from the metabolism of dietary tryptophan accumulating in patients with end-stage renal disease.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Not applicable
Faculty of Medicine, Benha University, Al Qalyūbīyah, Benha, Egypt
Patients with end-stage renal disease undergoing hemodialysis complaining of itching not related to other cause than renal failure will take activated charcoal with foods and serum level of indoxyl sulphate will be studied
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with end-stage renal failure with itching undergoing regular hemodialysis
Exclusion criteria
Patients with other causes of itching as psoriasis, atopic dermatitis, scabies, and lichen planus
Activated charcoal
Time frame: Two months
Change of severity of itching by The Visual Analogue Scale score
Benha University
Other
Does Indoxyl Sulfate Have a Role in Uremic Pruritus? A Laboratory and Interventional Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04950127
Bile Duct Diseases, Biliary Tract Diseases
Erlangen, Germany
View Trial DetailsNCT07641530
Hemodialysis, Pathological Conditions, Signs and Symptoms
Izmir, Turkey (Türkiye)
View Trial DetailsNCT06800755
Dry Skin, Pathological Conditions, Signs and Symptoms
Gdansk, Poland
View Trial DetailsNCT07478133
Pathological Conditions, Signs and Symptoms, Pruritus
Wuxi, Jiangsu, China
View Trial Details